Quinazoline and quinazoline-like compounds for the treatment of integrin-mediated disorders
US7081460B2 · kind B2 · utility
0Cited by
17References
45Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 5, 2002 |
| Grant date | Jul 25, 2006 |
| Priority date | — |
| Expiry date | Sep 27, 2023 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D413/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention is directed to novel quinazoline and quinazoline-like derivatives of Formula (I):useful as integrin antagonists and methods for the treatment of integrin-mediated disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.